Navigation Links
Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells

evels of expression of exogenous proteins typical of transiently transfected cells. It was therefore necessary to optimize our transfection experiments in order to produce enough positively transfected cells for data analysis. In an attempt to overcome these difficulties, we compared the effectiveness of two liposome-based transfection reagents in SW13 cells using pEGFP-C3 as a control vector.

Transient Transfection of the pEGFP-C3 Vector into SW13 Cells

SW13 cells (8 x 104) were plated in a 24-well culture dish and allowed to attach overnight so that the cell density was between 60% and 80% confluent. In order to compare the relative efficiencies of the two liposome-mediated reagents, we used the manufacturers recommendations for concentration of reagent and DNA as a starting point for our experiments. Additional transfections were performed that used more or less of either the reagent or DNA. All procedures were performed according to the manufacturers recommendations, including the use of serum-free media for LipofectAMINE reagent-mediated transfections and serum-enriched media when adding LipoTAXI transfection reagent and DNA solutions to SW13 cells. Cells were exposed to the DNA-liposome complex for 5 hours at 37C in a humidified incubator with 5% CO2. Serum-containing medium was added to the cells, and the cells were incubated overnight. Cells were then fixed with 4% paraformaldehyde at room temperature for 25 minutes and rinsed with deionized, distilled water. Coverslips with attached cells were mounted in glycerol containing 2.5% 1,4-diazabicyclo(2.2.2)octane (DABCO) then viewed and photographed using a Nikon Microphot FX light microscope. Transfection efficiency was determined by counting fluorescent and total cells from six random fields for each condition.

Figure 1 shows fluorescent images of
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
2. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
3. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
4. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
5. Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells
6. Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection of Mammalian Cells
7. High-Efficiency Transfections Achieved with New Low-Toxicity Reagent
8. Efficient Transfection of Neurospora Crassa
9. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
10. Efficient Transfection of Neurospora Crassa
11. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells

Post Your Comments:
(Date:12/2/2009)...CAMBRIDGE, Mass., Dec. 2 TechConne...n technology development and product integration i... the December 11th deadline for technology abstrac...th year, TechConnect World, in association with th...d the Clean Technology and Sustainable Industries ...
(Date:12/2/2009)... NANJING, China, Dec. 2 /PRNewswire-Asia/ -- Simce...") (NYSE: SCR ), a leading pharmaceutical compan...and marketing of branded,generic and proprietary p...of,its drugs have been included in China,s Nationa...ed by China,s Ministry of Human Resources and Soci...
(Date:12/2/2009)...EN, N.J., Dec. 2 According to the ...cent of Americans diagnosed with diabetes already ... retinopathy, damage to the retina caused by leaky...eople with diabetes and is one of the most feared ... of all patients who,ve had diabetes for 10 years ...
(Date:12/1/2009)...NEW YORK, Dec. 1 Reportlinker.com ...ilable in its catalogue: ,, Industrial Enzymes...tlinker.com/p0164431/Industrial-Enzymes---A-Global...et is an oligopoly with few strong players and a h...ivities. Keen competition and commoditization char...
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10
...8 Kosan Biosciences,Incorporated (Nasdaq: KOSN )...and nine months ended September 30, 2007. Net los...30, 2007 were,$11.1 million and $19.2 million, or ...net loss of $7.5 million and $24.9 million, or $0....ear. Revenues were $1.9 million and $17.1 million...
... Inverness Medical,Innovations, Inc. (Amex: IMA ...ject to market and other conditions, 7,000,000 sha...helf registration statement in an,underwritten pub...Company,are also offering to sell up to 165,698 sh...expects to grant the underwriters a 30-day option ...
... Inverness Medical,Innovations (Amex: IMA ) toda...with Chemogen, Inc. for the worldwide manufacture ...of Mycobacterium, the primary,causative agent of t...prietary antibodies for the detection of Lipoarabi...iagnosis of current mycobacterial infection,(inclu...
Other Biology Technology:Kosan Announces Third Quarter 2007 Financial Results 2Kosan Announces Third Quarter 2007 Financial Results 3Kosan Announces Third Quarter 2007 Financial Results 4Kosan Announces Third Quarter 2007 Financial Results 5Kosan Announces Third Quarter 2007 Financial Results 6Kosan Announces Third Quarter 2007 Financial Results 7Inverness Medical Innovations Announces Proposed Public Offering of Common Stock 2Inverness Medical Innovations Announces Proposed Public Offering of Common Stock 3Inverness - Chemogen Establish Exclusive License for TB Antibodies 2
(Date:12/3/2009)... , The UK leads the world when it comes to invest...t Engineering and Physical Sciences Research Counc...t more is needed: "Scientific and engineering rese...nd and solar power solutions, but more investment ... solutions if we are to meet our carbon emission t...
(Date:12/2/2009)... , , PHILADELPHIA Children exposed to secondhand...ing lung cancer in adulthood, even if they never s... Cancer Epidemiology, Biomarkers & Prevention , a...search, as part of a special tobacco focus in the ...9,000 Americans will be diagnosed with lung cancer...
(Date:12/2/2009)... , , PHILADELPHIA Cigarette smoking and alcohol ...strongly predicts the patient,s future risk of dea...f a new study show a similar effect among those wh..., "Most cancer survivors are counseled to quit sm...y, 21 percent continued to smoke even after their ...
Breaking Biology News(10 mins):Research is vital to a cleaner, greener, low carbon future 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Fox Soccer Channel and Fox Sports en Espanol Renew Every Goal Saves A Life Campaign With Malaria No More 55723 1Fox Soccer Channel and Fox Sports en Espanol Renew Every Goal Saves A Life Campaign With Malaria No More 55723 2Fox Soccer Channel and Fox Sports en Espanol Renew Every Goal Saves A Life Campaign With Malaria No More 55723 3Fox Soccer Channel and Fox Sports en Espanol Renew Every Goal Saves A Life Campaign With Malaria No More 55723 4New Technology Helps Athletes Prevent Dehydration and Heat Related Illness 55720 1New Technology Helps Athletes Prevent Dehydration and Heat Related Illness 55720 2Secca 28R 29 Therapy An Effective and Minimally Invasive Option for Treating Bowel Incontinence Launched in the US 55717 1Secca 28R 29 Therapy An Effective and Minimally Invasive Option for Treating Bowel Incontinence Launched in the US 55717 2
...ide to make proteins, key building blocks of all o... the instructions for assembling them. , An Iowa...hanism involved in marking where these instruction...dition of The Journal of Biological Chemistry , M...emistry, biophysics and molecular biology, along w...
...-- Researchers at Weill Cornell Medical College in... date palm genome, unlocking many of its genetic s... and initial assembly of the date palm using the m...r of the Genomics Laboratory at Weill Cornell Medi...e date palm is extremely valuable to researchers w...
...t evolution and creationism are often shaped by wh...es, according to a University of Minnesota study p...rnal of the American Institute of Biological Scien...professors in the College of Biological Sciences, ...y classes at the University of Minnesota to learn ...
Other Biology News:Genetic secrets of date palm unlocked by researchers at Weill Cornell Medical College in Qatar 2U of Minnesota study finds high school teachers influence student views of evolution & creationism 2
Yeast-GFP Collection from Invitrogen
...s can be used for the identification of potential ...r renal and other diseases. Due to the fact that u...nts, it provides an attractive alternative to bloo...rs. The ProteoSpin Urine Protein Concentration Mi...
... has joined forces with the Mickle Laboratory Engi...Tissue Chopper. This tissue sectioning system has ...tabolic experiments and to be especially applicabl...opsy or from small organs. Its special features ca...
Yeast-GFP 96-well Plates from Invitrogen
Biology Products: